Recruiting
Endometrial cancer metastatic
RecruitingA Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment
Registered drugNo placebo
A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment
Registered drugNo placebo
- Disease:Endometrial cancer metastatic
- Substances:AZD8205Doxorubicin+1
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:AZD8205



